FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Anglo American delivers steady EBITDA and advances Anglo Teck transaction in 2025

Underlying EBITDA rose to $6.4 billion in 2025 as Anglo American progressed divestments and secured key approvals for its merger with Teck...

SEGRO delivers strong FY2025 performance with record £99m new rent

For the year ended 31 December 2025, SEGRO achieved record leasing, 6.1% growth in adjusted earnings per share and a 6.0% rise in like-for-like net rental income...

AstraZeneca secures US Approval for fixed-duration Calquence regimen in CLL

AstraZeneca’s Calquence plus venetoclax has been approved in the US as the first all-oral, 14-month treatment option for adults with CLL and SLL, following Phase III data showing improved progression-free survival versus chemoimmunotherapy...

Reckitt Benckiser leadership to present at CAGNY 2026 conference

CEO Kris Licht and CFO Shannon Eisenhardt will present at the Consumer Analyst Group of New York (CAGNY) Conference 2026 in Orlando...

Rio Tinto reports higher EBITDA on 8% CuEq production growth

Rio Tinto PLC reported a 9% increase in underlying EBITDA to $25.4 billion for 2025, supported by an 8% rise in copper equivalent production and record iron ore output from Pilbara...

Centrica reports £1.4bn EBITDA and higher dividend for 2025

Centrica reported adjusted EBITDA of £1.4bn for the year ended 31 December 2025, down from £2.3bn in 2024, reflecting lower commodity prices and challenging trading conditions...

BAE Systems delivers record backlog and earnings growth in 2025

For the year ended 31 December 2025, BAE Systems posted 10% sales growth and a 12% increase in underlying EPS, supported by strong order intake of £36.8bn. The company issued 2026 guidance for continued sales and profit growth...

Glencore reports $13.5bn EBITDA in 2025, advances copper growth strategy

Glencore reported 2025 Adjusted EBITDA of $13.5 billion, down 6% year-on-year, with stronger second-half performance driven by improved copper production and metals prices...

Antofagasta delivers 30% revenue growth and 106% rise in underlying EPS in 2025

Antofagasta plc recorded record EBITDA and a widened margin of 60.3% in 2025, supported by robust copper pricing and operational discipline, CEO Iván Arriagada said...

Intertek strengthens solar PV services with AePVI acquisition

Intertek has acquired AePVI, a specialist in drone-based inspection solutions for solar PV systems, to expand its factory-to-field assurance services and improve defect detection, productivity, and performance across large-scale solar assets...

GSK secures EU approval for Exdensur in severe asthma and CRSwNP

GSK announced European Commission approval of Exdensur (depemokimab) as an add-on treatment for severe asthma with type 2 inflammation in patients aged 12 and older, and for adults with severe chronic rhinosinusitis with nasal polyps...

Ashtead Group announces Sunbelt Q3 results date and NYSE listing update

Ashtead Group's Sunbelt Rentals Holdings Inc will publish its third quarter results on March 12, 2026, with a live webcast at 8:30am ET. The company will assume the role of Ashtead Group’s holding company on February 27 and begin trading on the NYSE under “SUNB” on March 2, while maintaining its London listing...

NatWest launches 2026 share buyback of up to £750m

NatWest Group plc has started a share buyback programme of up to £750 million, effective 16 February 2026. The programme, conducted by UBS AG, London Branch, may run until January 2027 and will reduce the company’s issued share capital through the cancellation of repurchased shares...

NatWest Group posts higher profit and dividend growth in 2025

NatWest Group reported attributable profit of £5.5 billion for 2025, with earnings per share up 27% and dividends per share rising 51% year-on-year...

Auto Trader Reappoints KPMG as External Auditor from FY2027

Auto Trader Group plc has re-appointed KPMG LLP as its external auditor following a competitive tender process. The appointment will take effect from the financial year ending 31 March 2027, subject to shareholder approval at the 2026 AGM...

Isabelle Deschamps to Step Down from Rio Tinto Executive Role

Isabelle Deschamps will depart Rio Tinto in 2026 after serving as Chief Legal, Governance & Corporate Affairs Officer since 2021. The company said she will stay through at least mid-2026 to support leadership transition planning...

Severn Trent on track for environmental targets and record capital investment year

Severn Trent Plc says trading for the period to 10 February 2026 is in line with expectations, with strong operational momentum and capital investment expected at the top end of its £1.7–£1.9 billion guidance...

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International...

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress...
Search

Funds

October 23, 2024

Anglo American delivers steady EBITDA and advances Anglo Teck transaction in 2025

Underlying EBITDA rose to $6.4 billion in 2025 as Anglo American progressed divestments and secured key approvals for its merger with Teck...

SEGRO delivers strong FY2025 performance with record £99m new rent

For the year ended 31 December 2025, SEGRO achieved record leasing, 6.1% growth in adjusted earnings per share and a 6.0% rise in like-for-like net rental income...

AstraZeneca secures US Approval for fixed-duration Calquence regimen in CLL

AstraZeneca’s Calquence plus venetoclax has been approved in the US as the first all-oral, 14-month treatment option for adults with CLL and SLL, following Phase III data showing improved progression-free survival versus chemoimmunotherapy...

Reckitt Benckiser leadership to present at CAGNY 2026 conference

CEO Kris Licht and CFO Shannon Eisenhardt will present at the Consumer Analyst Group of New York (CAGNY) Conference 2026 in Orlando...

Rio Tinto reports higher EBITDA on 8% CuEq production growth

Rio Tinto PLC reported a 9% increase in underlying EBITDA to $25.4 billion for 2025, supported by an 8% rise in copper equivalent production and record iron ore output from Pilbara...

Centrica reports £1.4bn EBITDA and higher dividend for 2025

Centrica reported adjusted EBITDA of £1.4bn for the year ended 31 December 2025, down from £2.3bn in 2024, reflecting lower commodity prices and challenging trading conditions...

BAE Systems delivers record backlog and earnings growth in 2025

For the year ended 31 December 2025, BAE Systems posted 10% sales growth and a 12% increase in underlying EPS, supported by strong order intake of £36.8bn. The company issued 2026 guidance for continued sales and profit growth...

Glencore reports $13.5bn EBITDA in 2025, advances copper growth strategy

Glencore reported 2025 Adjusted EBITDA of $13.5 billion, down 6% year-on-year, with stronger second-half performance driven by improved copper production and metals prices...

Antofagasta delivers 30% revenue growth and 106% rise in underlying EPS in 2025

Antofagasta plc recorded record EBITDA and a widened margin of 60.3% in 2025, supported by robust copper pricing and operational discipline, CEO Iván Arriagada said...

Intertek strengthens solar PV services with AePVI acquisition

Intertek has acquired AePVI, a specialist in drone-based inspection solutions for solar PV systems, to expand its factory-to-field assurance services and improve defect detection, productivity, and performance across large-scale solar assets...

GSK secures EU approval for Exdensur in severe asthma and CRSwNP

GSK announced European Commission approval of Exdensur (depemokimab) as an add-on treatment for severe asthma with type 2 inflammation in patients aged 12 and older, and for adults with severe chronic rhinosinusitis with nasal polyps...

Ashtead Group announces Sunbelt Q3 results date and NYSE listing update

Ashtead Group's Sunbelt Rentals Holdings Inc will publish its third quarter results on March 12, 2026, with a live webcast at 8:30am ET. The company will assume the role of Ashtead Group’s holding company on February 27 and begin trading on the NYSE under “SUNB” on March 2, while maintaining its London listing...

NatWest launches 2026 share buyback of up to £750m

NatWest Group plc has started a share buyback programme of up to £750 million, effective 16 February 2026. The programme, conducted by UBS AG, London Branch, may run until January 2027 and will reduce the company’s issued share capital through the cancellation of repurchased shares...

NatWest Group posts higher profit and dividend growth in 2025

NatWest Group reported attributable profit of £5.5 billion for 2025, with earnings per share up 27% and dividends per share rising 51% year-on-year...

Auto Trader Reappoints KPMG as External Auditor from FY2027

Auto Trader Group plc has re-appointed KPMG LLP as its external auditor following a competitive tender process. The appointment will take effect from the financial year ending 31 March 2027, subject to shareholder approval at the 2026 AGM...

Isabelle Deschamps to Step Down from Rio Tinto Executive Role

Isabelle Deschamps will depart Rio Tinto in 2026 after serving as Chief Legal, Governance & Corporate Affairs Officer since 2021. The company said she will stay through at least mid-2026 to support leadership transition planning...

Severn Trent on track for environmental targets and record capital investment year

Severn Trent Plc says trading for the period to 10 February 2026 is in line with expectations, with strong operational momentum and capital investment expected at the top end of its £1.7–£1.9 billion guidance...

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International...

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress...
Search

Funds

FTSE 100

FTSE 100

Funds